A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Autolus Therapeutics plc’s current trading price is -13.06% away from its 52-week high, while its distance from the 52-week low is 105.94%. The stock’s price range for this time frame has been between $1.60 and $3.79. The trading volume of the company’s shares in the Healthcare reached around 0.97 million for the day, which was evidently higher than the average daily volume of 0.6 million over the last three months.
Currently, the stock price of Autolus Therapeutics plc (AUTL) is $3.30. In the most recent trading session, the stock underwent a significant upswing, peaking at $3.27 after opening at $3.22. The stock touched a low of $2.85 before closing at $3.11.
25-cent Stock Takes $11T Commodities Sector Digital
One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.
All the details are in the FREE online report you can get here.
Sponsored
Autolus Therapeutics plc’s stock has had a calm market performance. The 1-year high for the company’s stock was $3.79 on 08/15/22, and the lowest price during the same period was recorded at $1.60 on 12/12/22.
How Financial Performance Impacts Market Capitalization
Autolus Therapeutics plc (AUTL) has experienced a quarterly rise of 77.15% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 503.51M and boasts a workforce of 399 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 2.01, with a change in price of +1.41. Similarly, Autolus Therapeutics plc recorded 615,592 in trading volume during the last 100 days, posting a change of +74.21%.
How AUTL’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for AUTL stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
AUTL Stock Stochastic Average
The raw stochastic average for Autolus Therapeutics plc over the last 50 days is presently at 92.39%. This reflects a surge from the raw stochastic average of the previous 20 days, which was noted at 92.05%. Further, the company’s Stochastic %K and %D values for the last 20 days were 86.38% and 88.83%, respectively.
AUTL Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. This year’s metric has recorded a Price increase of 73.42%. However, over the past six months, we’ve seen a weaker performance of 39.62%. The price of AUTL fallen by 100.91% over the last 30 days. And in the last five days, it has surged by 19.82%.
